Medication info
Newjenta CR Tablets (Linagliptin, Metformin)

Newjenta CR Tablets (Linagliptin, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletLinagliptin Micronized›5mg / 1 tablet
Manufacturer / importer
Korea United Pharmaceutical Co., Ltd.
Appearance
White, double-sided, convex, elongated, sustained-release film-coated tablet
Packaging
60 tablets / box [10 tablets / PTP × 6]
Approval status
Active

MFDS item code 202400470 · Approved 2024.03.05 · Insurance code 644309770

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For antidiabetic therapy, patients receiving linagliptin 5mg and metformin hydrochloride (extended-release) 1000mg may take 1 tablet of this medicine once daily with a meal. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily with a meal, preferably in the evening. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. Because dose adjustment according to renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically thereafter. No dose adjustment is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60mL/min or estimated glomerular filtration rate (eGFR) ≧ 60mL/min/1.73 m2]. In patients with moderate renal impairment (CKD stage 3A), with creatinine clearance (CrCl) of 45mL/min or more and less than 60mL/min, or estimated glomerular filtration rate (eGFR) of 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, this medicine may be used with dose adjustment of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. The starting dose of extended-release metformin hydrochloride is 500mg or 750mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to less than 45mL/min or estimated glomerular filtration rate (eGFR) decreases to less than 45mL/min/1.73m2, this medicine must be discontinued immediately.

Ingredients

Manufacturer
Korea United Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. The ingredients Linagliptin and Metformin work together to effectively lower and regulate blood sugar levels. Regular intake will greatly assist in improving blood sugar management.

How to take

Adult dose

For antidiabetic therapy, patients receiving linagliptin 5mg and metformin hydrochloride (extended-release) 1000mg may take 1 tablet of this medicine once daily with a meal. To reduce gastrointestinal adverse reactions caused by metformin, take this medicine once daily with a meal, preferably in the evening. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. Because dose adjustment according to renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically thereafter. No dose adjustment is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60mL/min or estimated glomerular filtration rate (eGFR) ≧ 60mL/min/1.73 m2]. In patients with moderate renal impairment (CKD stage 3A), with creatinine clearance (CrCl) of 45mL/min or more and less than 60mL/min, or estimated glomerular filtration rate (eGFR) of 45mL/min/1.73m2 or more and less than 60mL/min/1.73m2, this medicine may be used with dose adjustment of metformin hydrochloride as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. The starting dose of extended-release metformin hydrochloride is 500mg or 750mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to less than 45mL/min or estimated glomerular filtration rate (eGFR) decreases to less than 45mL/min/1.73m2, this medicine must be discontinued immediately.

Precautions

This medication can rarely cause severe lactic acidosis or hypoglycemia, so it should be used with caution. In particular, it should not be used in patients with severely impaired kidney function or liver dysfunction, or in cases of acute infection or dehydration. It is also unsafe for pregnant women or those with severe heart diseases such as congestive heart failure or acute myocardial infarction to take this medication. Patients should be vigilant for symptoms of hypoglycemia during treatment, and the risk of hypoglycemia may increase if used in conjunction with sulfonylureas or insulin. If symptoms of lactic acidosis such as muscle cramps, abdominal pain, or weakness occur, notify a doctor immediately, and the use of this medication should be determined based on kidney function. Additionally, if iodinated contrast agents are used during radiological examinations, this medication should be temporarily discontinued and resumed only after kidney function has recovered. Patients scheduled for surgery should stop taking this medication 48 hours prior to surgery and may restart it once kidney function has normalized post-operation. This medication should be swallowed whole without chewing or breaking it. It is normal for the outer coating of the tablet to appear in the stool. If symptoms suggestive of acute pancreatitis or blistering skin conditions arise during treatment, the patient should stop the medication immediately and consult a doctor. Long-term use may reduce vitamin B12 levels, so regular blood tests to monitor this are necessary. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist about any other medications being taken. Elderly patients are commonly at risk for reduced kidney function, so kidney function should be evaluated before administration and dosage adjustments may be necessary. Women who are pregnant or breastfeeding should avoid using this medication. In cases of overdose, there is a risk of lactic acidosis, and immediate medical attention is required. Keep out of reach of children, store in a moisture-free environment, and keep in the original container.

Side effects

Severe lactic acidosis, hypoglycemia, angioedema, urticaria, lactic acidosis, abnormal vitamin B12 absorption test, hypoglycemic episode, taste disturbance, cough, decreased appetite, diarrhea, constipation, nausea, pancreatitis, vomiting, abdominal pain, oral ulcer, abnormal liver function tests, hepatitis, pruritus, erythema, rash, pseudo-pemphigus, severe and disability-associated arthralgia, rhabdomyolysis, increased lipase levels, increased amylase, nasopharyngitis, hypersensitivity reaction, constipation, upper abdominal pain, enterocolitis, bowel obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, stuttering, Alzheimer-type dementia, chest pain, fever, facial edema, fatigue, chronic obstructive pulmonary disease, asthma, diabetic foot disease, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, stomach cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, osteo fracture, hand fracture, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, goiter, anemia, nausea, gastroesophageal reflux disease, dizziness, sensory impairment, chest discomfort, asthenia, nosebleed, oropharyngeal pain, voice disorder, allergic rhinitis, exertional dyspnea, wet cough, runny nose, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased serum triglycerides, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine phosphokinase, increased ALT, male pattern baldness, hyperhidrosis, dermatitis, anxiety, confusional state, nocturia, dermatitis, hypertension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. To maintain the drug's efficacy, it is important to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White, double-sided, convex, elongated, sustained-release film-coated tablet

Package unit

60 tablets / box [10 tablets / PTP × 6]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.